S100A2 and neoplasm: RNA sequencing results revealed significant differences in gene expression, with key genes (upregulated CXCR4, OPCML, and S100A2, and downregulated ATP1A3, CHL1, HLA-DRA, and IL-1β) associated with tumor invasiveness.